Results 11 to 20 of about 29 (27)

Translational Development Strategies for TAK-063, a Phosphodiesterase 10A Inhibitor

International Journal of Neuropsychopharmacology, 2020
Thomas A Macek, Kazunori Suzuki, Haruhide Kimura   +2 more
exaly  

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study

Journal of Child and Adolescent Psychopharmacology, 2020
Andrew J Cutler, Graeme A E Donnelly, Ann Childress   +2 more
exaly  

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021
Mitra Nejad, Saba Al-Hashimi
exaly  

Biosynthesis of p-methoxyphenylacetic acid from p-methoxyphenylacetonitrile by immobilized Bacillus subtilis ZJB-063

Process Biochemistry, 2008
Yu-Guo Zheng
exaly  

A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects

Psychopharmacology, 2019
Deborah A Yurgelun-Todd, Perry F Renshaw, Thomas A Macek   +2 more
exaly  

Description of the novel KIR3DL3*063 allele identified in a Southern Chinese Han individual

Hla, 2019
Z -H Deng, Guobin Zhang, S -Q Cai
exaly  

The phosphodiesterase 10A selective inhibitor, TAK-063, induces c-Fos expression in both direct and indirect pathway medium spiny neurons and sub-regions of the medial prefrontal cortex in rats

Neuroscience Research, 2017
Atsushi Nakatani, Haruhide Kimura
exaly  

Combined treatment with a selective PDE10A inhibitor TAK‐063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic‐like effects without affecting plasma prolactin levels and cataleptic responses in rodents

Pharmacology Research and Perspectives, 2018
Kazunori Suzuki, Haruhide Kimura
exaly  

Patent Reviews: 3,990,087; 3,997,248; 4,007,989; 4,008,952; 4,013,346; 4,013,348; 4,019,810; 4,019,813; 4,022,531; 4,023,189; 4,025,167; 4,025,168; 4,025,169; 4,025,170; 4,028,725; 4,033,675; 4,035,063

Applied Optics, 1978
exaly  

In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents

Journal of Pharmacology and Experimental Therapeutics, 2015
Kazunori Suzuki, Haruhide Kimura
exaly